Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 44

    1.

    NIH conference. HIV vaccine development: a progress report.

    Hoth DF, Bolognesi DP, Corey L, Vermund SH.

    Ann Intern Med. 1994 Oct 15;121(8):603-11. Review.PMID: 8085693 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Issues in the development of a prophylactic HIV vaccine.

    Hoth DF.

    Ann N Y Acad Sci. 1993 Jun 23;685:777-83. Review. No abstract available. PMID: 8363285 [PubMed - indexed for MEDLINE]Related articles

    3.

    Present status and future prospects for HIV therapies.

    Johnston MI, Hoth DF.

    Science. 1993 May 28;260(5112):1286-93. Review.PMID: 7684163 [PubMed - indexed for MEDLINE]Related articles

    4.

    HIV vaccine trials: some design issues including sample size calculation.

    Dixon DO, Rida WN, Fast PE, Hoth DF.

    J Acquir Immune Defic Syndr. 1993 May;6(5):485-96.PMID: 8483112 [PubMed - indexed for MEDLINE]Related articles

    5.

    The use of external monitoring committees in clinical trials of the National Institute of Allergy and Infectious Diseases.

    Ellenberg SS, Myers MW, Blackwelder WC, Hoth DF.

    Stat Med. 1993 Mar;12(5-6):461-7; discussion 469.PMID: 8493424 [PubMed - indexed for MEDLINE]Related articles

    6.

    Current status of HIV therapy: II. Opportunistic diseases.

    Feinberg J, Hoth DF Jr.

    Hosp Pract (Off Ed). 1992 Sep 15;27(9):161-4, 167-9, 173-4. Review.PMID: 1522156 [PubMed - indexed for MEDLINE]Related articles

    7.

    Current status of HIV therapy: I. Antiretroviral agents.

    Hoth DF Jr, Myers MW, Stein DS.

    Hosp Pract (Off Ed). 1992 Sep 15;27(9):145-56. Review.PMID: 1381716 [PubMed - indexed for MEDLINE]Related articles

    8.

    Studying treatments for AIDS: new challenges for clinical trials--a panel discussion at the 1990 annual meeting of the Society for Clinical Trials.

    Ellenberg SS, Cooper E, Eigo J, Finkelstein DM, Hoth DF, Nusinoff-Lehrman S, Sacks H.

    Control Clin Trials. 1992 Aug;13(4):272-92. No abstract available. PMID: 1330433 [PubMed - indexed for MEDLINE]Related articles

    9.

    Surrogate markers in AIDS: where are we? Where are we going?

    Lagakos SW, Hoth DF.

    Ann Intern Med. 1992 Apr 1;116(7):599-601. No abstract available. PMID: 1347443 [PubMed - indexed for MEDLINE]Related articles

    10.

    Current status of HIV therapy: II. Opportunistic diseases.

    Feinberg J, Hoth DF Jr.

    Hosp Pract (Off Ed). 1991 Mar 15;26(3):105-13.PMID: 1900845 [PubMed - indexed for MEDLINE]Related articles

    11.

    Current status of HIV therapy: I. Antiretroviral agents.

    Hoth DF Jr, Myers MW.

    Hosp Pract (Off Ed). 1991 Jan 15;26(1):174-9, 183-4, 189 passim.PMID: 1702791 [PubMed - indexed for MEDLINE]Related articles

    12.

    How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus?

    Vermund SH, Hoth DF.

    Ann Epidemiol. 1990 Dec;1(2):141-55. Review.PMID: 1669495 [PubMed - indexed for MEDLINE]Related articles

    13.

    Aerosolized pentamidine and Pneumocystis carinii pneumonia.

    Montgomery AB, Feigal DW, Luce JM, Hopewell PC, Hoth DF, Myers MW, Feinberg JE, Mills J, Sattler FR.

    Ann Intern Med. 1989 Apr 15;110(8):669. No abstract available. PMID: 2648925 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hypersensitivity reactions to deoxycoformycin.

    O'Dwyer PJ, King SA, Eisenhauer E, Grem JL, Hoth DF.

    Cancer Chemother Pharmacol. 1989;23(3):173-5.PMID: 2784360 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pyrazole: preclinical reassessment.

    O'Dwyer PJ, King SA, Plowman J, Grieshaber CK, Hoth DF, Leyland-Jones B.

    Invest New Drugs. 1988 Dec;6(4):305-10. Review.PMID: 3068185 [PubMed - indexed for MEDLINE]Related articles

    16.

    Development and testing of AIDS vaccines.

    Koff WC, Hoth DF.

    Science. 1988 Jul 22;241(4864):426-32. Review.PMID: 3293212 [PubMed - indexed for MEDLINE]Related articles

    17.

    Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.

    O'Dwyer PJ, Cheson BD, Leyland-Jones B, King SA, Hoth DF.

    Oncology (Williston Park). 1988 Jun;2(6):17-23, 26-7. Review.PMID: 3079330 [PubMed - indexed for MEDLINE]Related articles

    18.

    N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer.

    Clagett-Carr K, Sarosy G, Plowman J, Hoth DF, Leyland-Jones B.

    J Clin Oncol. 1988 May;6(5):906-18. Review.PMID: 3284976 [PubMed - indexed for MEDLINE]Related articles

    19.

    2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.

    O'Dwyer PJ, Wagner B, Leyland-Jones B, Wittes RE, Cheson BD, Hoth DF.

    Ann Intern Med. 1988 May;108(5):733-43. Review.PMID: 3282467 [PubMed - indexed for MEDLINE]Related articles

    20.

    Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.

    Grem JL, Hoth DF, Leyland-Jones B, King SA, Ungerleider RS, Wittes RE.

    J Clin Oncol. 1988 Feb;6(2):351-79. Review.PMID: 3276827 [PubMed - indexed for MEDLINE]Related articles

    21.

    Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.

    Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B.

    Cancer Treat Rep. 1987 Dec;71(12):1249-64. Review. No abstract available. PMID: 3319136 [PubMed - indexed for MEDLINE]Related articles

    22.

    Arabinosyl-5-azacytosine: a novel nucleoside entering clinical trials.

    Grem JL, Shoemaker DD, Hoth DF, King SA, Plowman J, Zaharko D, Grieshaber CK, Harrison SD Jr, Cradock JC, Leyland-Jones B.

    Invest New Drugs. 1987 Dec;5(4):315-28. Review.PMID: 2449402 [PubMed - indexed for MEDLINE]Related articles

    23.

    Role of thymidine in biochemical modulation: a review.

    O'Dwyer PJ, King SA, Hoth DF, Leyland-Jones B.

    Cancer Res. 1987 Aug 1;47(15):3911-9. Review.PMID: 3300957 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Azacitidine: 10 years later.

    Glover AB, Leyland-Jones BR, Chun HG, Davies B, Hoth DF.

    Cancer Treat Rep. 1987 Jul-Aug;71(7-8):737-46. Review.PMID: 2440570 [PubMed - indexed for MEDLINE]Related articles

    25.

    Indicine N-oxide: clinical use of a pyrrolizidine alkaloid.

    King SA, Suffness M, Leyland-Jones B, Hoth DF, O'Dwyer PJ.

    Cancer Treat Rep. 1987 May;71(5):517-23. Review. No abstract available. PMID: 3552221 [PubMed - indexed for MEDLINE]Related articles

    26.

    Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.

    O'Dwyer PJ, Shoemaker D, Zaharko DS, Grieshaber C, Plowman J, Corbett T, Valeriote F, King SA, Cradock J, Hoth DF, et al.

    Cancer Chemother Pharmacol. 1987;19(1):6-10. Review.PMID: 3545524 [PubMed - indexed for MEDLINE]Related articles

    27.

    Methodology for the rational development of methotrexate analogs in the clinic.

    Leyland-Jones B, O'Dwyer PJ, Hoth DF, Wittes RE.

    NCI Monogr. 1987;(5):93-7.PMID: 3481041 [PubMed - indexed for MEDLINE]Related articles

    28.

    5-Methyltetrahydrohomofolate.

    O'Dwyer PJ, Wagner BH, Hoth DF, Leyland-Jones B.

    Invest New Drugs. 1987;5(3):215-8. Review.PMID: 3312079 [PubMed - indexed for MEDLINE]Related articles

    29.

    Trimetrexate: clinical development of a nonclassical antifolate.

    O'Dwyer PJ, DeLap RJ, King SA, Grillo-Lopez AJ, Hoth DF, Leyland-Jones B.

    NCI Monogr. 1987;(5):105-9.PMID: 2963228 [PubMed - indexed for MEDLINE]Related articles

    30.

    Homoharringtonine--perspectives on an active new natural product.

    O'Dwyer PJ, King SA, Hoth DF, Suffness M, Leyland-Jones B.

    J Clin Oncol. 1986 Oct;4(10):1563-8. Review. No abstract available. PMID: 3531426 [PubMed - indexed for MEDLINE]Related articles

    31.

    Central nervous system toxicity of fludarabine phosphate.

    Chun HG, Leyland-Jones BR, Caryk SM, Hoth DF.

    Cancer Treat Rep. 1986 Oct;70(10):1225-8.PMID: 2428492 [PubMed - indexed for MEDLINE]Related articles

    32.

    Clinical development of biological response modifiers: comparison with cytotoxic drugs.

    Hawkins MJ, Hoth DF, Wittes RE.

    Semin Oncol. 1986 Jun;13(2):132-40. Review. No abstract available. PMID: 3520823 [PubMed - indexed for MEDLINE]Related articles

    33.

    Site visit monitoring program of the clinical cooperative groups: results of the first 3 years.

    Mauer JK, Hoth DF, Macfarlane DK, Hammershaimb LD, Wittes RE.

    Cancer Treat Rep. 1985 Oct;69(10):1177-87. No abstract available. PMID: 4042096 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.

    Broder S, Yarchoan R, Collins JM, Lane HC, Markham PD, Klecker RW, Redfield RR, Mitsuya H, Hoth DF, Gelmann E, et al.

    Lancet. 1985 Sep 21;2(8456):627-30.PMID: 2863631 [PubMed - indexed for MEDLINE]Related articles

    35.

    Dichloromethotrexate--a critical reassessment.

    O'Dwyer PJ, Leyland-Jones B, Alonso MT, Eisenberger M, Hoth DF.

    J Clin Oncol. 1985 Aug;3(8):1148-53. No abstract available. PMID: 4020413 [PubMed - indexed for MEDLINE]Related articles

    36.

    Hypersensitivity reactions to amsacrine.

    Perry DJ, Weiss RB, Hoth DF.

    Cancer Treat Rep. 1985 Feb;69(2):199-201.PMID: 3155993 [PubMed - indexed for MEDLINE]Related articles

    37.

    Anaphylactic reactions to diaziquone.

    Posada JG, O'Dwyer PJ, Hoth DF.

    Cancer Treat Rep. 1984 Oct;68(10):1215-7.PMID: 6525594 [PubMed - indexed for MEDLINE]Related articles

    38.

    Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung.

    Killen JY, Mitchell EP, Hoth DF, Willis LL, Gullo JJ, Smith FP, Schein PS, Woolley PV.

    Cancer. 1982 Oct 1;50(7):1258-61.PMID: 7104970 [PubMed - indexed for MEDLINE]Related articles

    39.

    The FAM regimen for gastric cancer: a progress report.

    Schein PS, Macdonald JS, Woolley PV, Smith FP, Hoth DF, Boiron M, Gisselbrecht C, Brunet R, Lagarde C.

    Recent Results Cancer Res. 1981;76:241-3. No abstract available. PMID: 6785849 [PubMed - indexed for MEDLINE]Related articles

    40.

    5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.

    Smith FP, Hoth DF, Levin B, Karlin DA, MacDonald JS, Woolley PV 3rd, Schein PS.

    Cancer. 1980 Nov 1;46(9):2014-8.PMID: 7427908 [PubMed - indexed for MEDLINE]Related articles

    41.

    A phase II study of chlorozotocin in metastatic malignant melanoma.

    Hoth DF, Schein PS, Winokur S, Woolley PV, Robichaud K, Binder RB, Smith FP.

    Cancer. 1980 Oct 1;46(7):1544-7.PMID: 6448088 [PubMed - indexed for MEDLINE]Related articles

    42.

    Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.

    Gullo JJ, Litterst CL, Maguire PJ, Sikic BI, Hoth DF, Woolley PV.

    Cancer Chemother Pharmacol. 1980;5(1):21-6.PMID: 6161715 [PubMed - indexed for MEDLINE]Related articles

    43.

    A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinoma.

    Woolley PV 3rd, MacDonald JS, Smythe T, Haller DG, Hoth DF, Rosenoff S, Schein PS.

    Cancer. 1979 Oct;44(4):1211-4.PMID: 387203 [PubMed - indexed for MEDLINE]Related articles

    44.

    Natural history and staging of colon cancer.

    Hoth DF, Petrucci PE.

    Semin Oncol. 1976 Dec;3(4):331-6. Review. No abstract available. PMID: 793009 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...